Medvest

What is Medvest?

MedVest is an early-stage venture capital firm with a clear focus on the biotech and medical sectors. Specializing in Seed, Series A, and other early investment stages, MedVest targets innovative startups at the intersection of medical technology, diagnostics, and digital health.

They operate out of London, United Kingdom, and have carved out a niche by providing not only capital but also strategic assistance to steer companies towards commercialization and growth.

MedVest's approach is to take a significant or controlling stake in their portfolio companies.

This enables them to contribute to shaping the strategic direction and governance of these ventures. MedVest is not just a passive investor; they play an active role in leading the companies to funding rounds, drawing on their extensive industry experience and networks.

What sets MedVest apart is their emphasis on improving safety, efficiency, and patient treatment. Their investment thesis is deeply rooted in advancing healthcare delivery through digitalization and enabling patient care beyond the traditional hospital setting, which is increasingly relevant in the context of the ongoing pandemic.

The firm's portfolio includes a blend of hospital-based and digital health companies, each holding registered patents to safeguard their intellectual property. MedVest's seasoned operational team, along with a medical advisory board, works hands-on with each portfolio company, offering guidance in startup operations, IPOs, mergers, acquisitions, and overall life sciences industry navigation.

The team's shared history of over a decade ensures a synergetic collaboration to expedite the process of bringing transformative medical solutions from the lab bench to the bedside.